Hemocue America Hemocue Hemoccult Single Slide (Test Cards)

Yes, the Hemoccult Single Slide is a guaiac-based Fecal Occult Blood Test (FOBT) designed to detect abnormal occult bleeding.

Occult bleeding refers to microscopic amounts of blood in the stool that are invisible to the naked eye. Detecting this is essential as it can indicate underlying gastrointestinal disorders.

This test is particularly valuable because:

• Targeted Screening: It helps screen for bleeding potentially associated with various GI disorders, including colorectal cancer.
• Proven Efficacy: Hemoccult is the only FOBT clinically proven to reduce the incidence and mortality of colorectal cancer when utilized for annual screening.
• Regulatory Status: It is classified as CLIA Waived, which simplifies regulatory compliance for testing in various clinical and laboratory environments.

Yes, the Hemoccult Single Slide is designated as CLIA Waived.

This classification simplifies regulatory requirements, making the test suitable for a variety of clinical and laboratory settings.

As a guaiac-based Fecal Occult Blood Test (FOBT), Hemoccult is also highly effective when used for annual screening:

• It helps detect abnormal occult bleeding associated with gastrointestinal disorders.
• It is clinically proven to reduce the incidence and mortality of colorectal cancer.

Yes, the Hemoccult Single Slide product is provided as a comprehensive, all-inclusive kit for performing the guaiac-based Fecal Occult Blood Test (FOBT). The system is CLIA Waived, making it suitable for standard clinical environments for annual screening.

All configurations include the following necessary components:

• Hemoccult Single Slides (Test Cards)
• Developer Solution (supplied in 15mL bottles)
• Applicators for hygienic sample collection
• Instructions for proper administration and use

The specific quantity of slides, developer bottles, and applicators varies depending on the bulk configuration selected.

Yes, the Hemoccult Single Slide is clinically proven for effective colorectal cancer screening.

It is the only guaiac-based Fecal Occult Blood Test (FOBT) that has been clinically validated to reduce the incidence and mortality of colorectal cancer when used for annual screening protocols.

Key features and benefits of this test include:

• Intended Use: Specifically designed to detect abnormal occult bleeding associated with various gastrointestinal disorders.
• Regulatory Status: The test is CLIA Waived, which simplifies regulatory compliance for certain clinical facilities.
• Methodology: It utilizes a reliable guaiac-based testing method.
• Ease of Use: The test is safe and simple to administer.

Yes, the Hemoccult Single Slide is a highly reliable, guaiac-based Fecal Occult Blood Test (FOBT) that has demonstrated clinical efficacy in screening. This test is uniquely positioned as the only FOBT clinically proven to reduce the incidence and mortality of colorectal cancer when used for annual screening protocols. Furthermore, this product is:

• CLIA Waived: Meets the requirements under the Clinical Laboratory Improvement Amendments, simplifying regulatory compliance and allowing for safe and simple administration in various settings.
• Targeted Screening: Intended specifically for detecting abnormal occult bleeding associated with gastrointestinal disorders.

Yes, this test kit has specific shipping restrictions because the developer solution is classified as a Hazardous Material (HAZMAT). These limitations are particularly relevant for bulk configurations:

• The product cannot be shipped via air transport.
• Shipments are generally restricted to the Continental US Only.
• Shipping is explicitly excluded for the following territories: Alaska (AK), Guam (GU), Hawaii (HI), Mariana Islands (MP), Puerto Rico (PR), and U.S. Virgin Islands (VI).

Please also note that bulk configurations of this item are listed as Non-Returnable.

Yes, the Hemoccult Single Slide configuration is a comprehensive system designed for conducting the guaiac-based Fecal Occult Blood Test (FOBT). The kits include all necessary components for screening:

• Hemoccult Single Slides (Test Cards)
• Developer Solution (supplied in 15mL bottles)
• Applicators for sample collection
• Detailed Instructions

Key Benefits

This test system is CLIA Waived, simplifying regulatory compliance for certain testing environments. It is also clinically proven to reduce the incidence and mortality of colorectal cancer when utilized for annual screening.

Shipping Restriction

Due to the developer solution, this product is classified as HAZMAT (Hazardous Material). It cannot ship via air and is subject to specific geographical shipping restrictions, which vary based on the configuration selected.

Yes, the Hemoccult Single Slide test cards are confirmed to be CLIA Waived.

This important regulatory status indicates compliance with the Clinical Laboratory Improvement Amendments (CLIA) regulations, which simplifies testing requirements for various clinical environments.

As a guaiac-based Fecal Occult Blood Test (FOBT), the Hemoccult system is also clinically proven for use in annual screening protocols to reduce the incidence and mortality associated with colorectal cancer.

Yes, the Hemoccult Single Slide is a highly reliable and clinically validated guaiac-based Fecal Occult Blood Test (FOBT). It is designed to safely and simply detect abnormal occult bleeding associated with gastrointestinal disorders. Its strong clinical profile includes:

• Clinically Proven Efficacy: Hemoccult is uniquely positioned as the only FOBT clinically proven to reduce the incidence and mortality of colorectal cancer when utilized for annual screening.
• Regulatory Compliance: This test is CLIA Waived, which simplifies regulatory requirements for its use in various clinical settings.
• Ease of Use: The methodology is characterized as both safe and simple to administer, making it suitable for high-volume screening programs.

Yes, the Hemoccult Single Slide is designated as CLIA Waived.

This is a significant benefit, as it means the product meets the requirements for use in a wide variety of clinical settings that hold a CLIA waiver (Clinical Laboratory Improvement Amendments), allowing for simpler regulatory compliance.

The test itself is a straightforward, guaiac-based Fecal Occult Blood Test (FOBT) clinically proven for use in annual colorectal cancer screening protocols.